AMLX's logo.
Ticker Symbol: AMLX

Amylyx Pharmaceuticals Inc

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001658551

Company Profile

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.

Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: amylyx.com
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $16.84
Change: $0.28 ( 1.75%)
Days Range: $16.57 - $17.13
Beta: 0.96
52wk. High: $41.93
52wk. Low: $16.52
Ytd. Change -52.67%
50 Day Moving Average: $18.63
200 Day Moving Average: $23.29
Shares Outstanding: 67377743

Valuation

Market Cap: 113.5B
PE Ratio: -15.31
EPS (TTM): -1.1

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A